Skip to main content
Log in

In vitro biotransformation of estradiol by explant cultures of murine mammary tissues

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

In vivo experiments have demonstrated a correlation between the extent of 16α-hydroxylation of estradiol and incidence of mammary cancer. The ability of mammary ductal epithelium (MDE), the site for neoplastic transformation, to metabolize estradiol or to accumulate estradiol metabolites has not been unequivocally established. Using a newly developed mammary explant culture system and a radiometric assay, we have compared the site-specific metabolism of estradiol (E2) by the C-17-oxidation and C-16α-hydroxylation pathways in mouse tissues that differ in relative risk for mammary cancer. A comparison between MDE (target tissue) and liver (nontarget tissue) from NFS (low risk) and C3H/ouj (high risk) mice revealed that: a) increase in C-17-oxidation was similar in MDE and liver from the two strains, and b) while C-16α-hydroxylation was similar in liver from the two strains (p = 0.5, n.s.), it was increased 4-fold in the MDE from the high risk C3H/ouj strain relative to that from the low risk NFS strain (p = 0.001). Furthermore,in vivo administration of progesterone resulted in modulation of cell proliferation as well as of E2 metabolism in mammary explant cultures. The effect of progesterone depended upon the presence of the MtV-2 proviral gene. This study demonstrates that mammary explants can extrahepatically metabolize estradiol. The specific risk-related increase in C-16α-hydroxylation suggests that intrinsic metabolic ability of the target tissue leading to the formation of 16α-hydroxyestrone from estradiol may be a determinant in the relative risk for developing mammary cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abbreviations

MMTV:

Mouse Mammary Tumor Virus

E1 :

estrone

2-OHE1 :

2-hydroxyestrone

16α-OHE1 :

16α-hydroxyestrone

MDE:

Mammary Ductal Epithelium

HN:

Hyperplastic Nodule

MtV-2:

Proviral Gene of Mammary Tumor Virus

GRSMtV-2+ :

GRS strain of mouse carrying MtV-2 proviral gene

GRSMtV-2- :

GRS strain of mouse lacking MtV-2 proviral gene

020MtV-2- :

020 strain of mouse lacking MtV-2 proviral gene

020MtV-2+ :

020 strain of mouse carrying MtV-2 proviral gene

References

  1. Nandi S, McGrath CM: Mammary neoplasia in mice. Adv Cancer Res 17: 354–414, 1973

    Google Scholar 

  2. Medina D: Preneoplastic lesions in murine mammary cancer. Cancer Res 36: 3584–3595, 1976

    PubMed  Google Scholar 

  3. Banerjee MR: Responses of mammary cells to hormones. Int Rev Cytol 4: 1–97, 1976

    Google Scholar 

  4. Banerjee MR: Anin vitro model for neoplastic transformation of epithelial cells in an isolated whole mammary organ of the mouse. In: Weber MM, Sekely LI (eds)In Vitro Models for Cancer Research. CRC Press, Boca Raton, Florida, 1986, Vol III, pp 69–114

    Google Scholar 

  5. Banerjee MR, Ganguly N, Mehta NM, Iyer AP, Ganguly R: Functional differentiation and neoplastic transformation in an isolated whole mammary organin vitro. In: McGrath CM, Brennan M, Rich M (eds) Cell Biology of Breast Cancer. Academic Press, New York, 1980, pp 485–516

    Google Scholar 

  6. Zumoff BJ, Fishman J, Bradlow HL, Hellman L: Hormone profiles in hormone dependent cancers. Cancer Res 35: 3365–3373, 1975

    PubMed  Google Scholar 

  7. Schneider J, Kinne D, Fracchia A, Pierce V, Anderson KE, Bradlow HL, Fishman J: Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc Natl Acad Sci USA 79: 3047–3051, 1982

    PubMed  Google Scholar 

  8. Osborne MP, Bradlow HL, Hershcopf R, Fishman J: A potential marker for the risk of breast cancer: Abnormal estradiol 16α-hydroxylation. Soc Surg Oncol 1984(abstr)

  9. Bradlow HL, Hershcopf RJ, Martucci CP, Fishman J: Estradiol 16α-hydroxylation correlates with mammary tumor incidence and the presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. Proc Natl Acad Sci USA 82: 6295–6299, 1985

    PubMed  Google Scholar 

  10. Bradlow HL, Hershcopf RJ, Martucci CP, Fishman J: 16α-hydroxylation of estradiol: a possible risk marker for breast cancer. Ann NY Acad Sci 464: 138–151, 1986

    PubMed  Google Scholar 

  11. Van der Valk MA: Survival, tumor incidence and gross pathology in 33 mouse strains. In: Hilgers J, Sluyser M (eds) Mammary Tumors in the Mouse. Elsevier/North Holland Biomedical Press, Amsterdam, 1981, pp 46–115

    Google Scholar 

  12. Van Nie R, DeMoes J: Development of a congenic line of GR mouse strain without early mammary tumors. Int J Cancer 20: 588–594, 1977

    PubMed  Google Scholar 

  13. Michalides R, Van Nie R, Nusse R, Hynes NE, Groner B: Mammary tumor induction loci in GR and DBAf mice contain one provirus of the mouse mammary tumor virus. Cell 23: 165–173, 1981

    PubMed  Google Scholar 

  14. Telang NT, Sarkar NH: Long term survival of adult mouse mammary glands in culture and their response to a retinoid. Cancer Res 43: 4891–4900, 1983

    PubMed  Google Scholar 

  15. Telang NT, Bockman RS, Sarkar NH: Fatty acid-induced modifications of mouse mammary alveolar lesions in organ culture. Carcinogenesis 5: 1123–1127, 1984

    PubMed  Google Scholar 

  16. Fishman J, Bradlow HL, Schneider J, Anderson KE, Kappas A: Radiometric analysis of oxidation in man: Sex differences in estradiol metabolism. Proc Natl Acad Sci USA 77: 4957–4960, 1980

    PubMed  Google Scholar 

  17. McGrath CM: Replication of mammary tumor virus in tumor cell cultures. Dependence on hormone induced cellular organization. J Natl Cancer Inst 47: 455–467, 1971

    PubMed  Google Scholar 

  18. Young HA, Scolnick EM, Parks WP: Glucocorticoid receptor interaction and induction of murine mammary tumor virus. J Biol Chem 250: 3337–3343, 1975

    PubMed  Google Scholar 

  19. Prudhomme JF, Malet C, Gompel A, Lalardrie JP, Ochoa P, Boue A, Mauvais-Jarvis P, Kuttenn F: 17β-hydroxysteroid dehydrogenase activity in human breast epithelial and fibroblast cell cultures. Endocrinology 114: 1483–1489, 1984

    PubMed  Google Scholar 

  20. Mauvais-Jarvis P, Kuttenn F, Gompel A: Estradiol/progesterone interaction in normal and pathologic breast cells. Ann NY Acad Sci 464: 152–167, 1986

    PubMed  Google Scholar 

  21. Sluyser M, Verstraeten RA, Van Nie R: Effects of hormones on the expression of proviral genes MtV-2 and MtV-3 in mouse mammary gland. Int J Cancer 31: 217–221, 1983

    PubMed  Google Scholar 

  22. Philibert D: RU-38486: An original multifaceted antihormone in vivo. In: Agarwal MK (ed) Adrenal Steroid Antagonism. de Gruyter & Co., Berlin, 1985, pp 77–101

    Google Scholar 

  23. Telang NT, Banerjee MR, Iyer AP, Kundu AB: Neoplastic transformation of epithelial cells in whole mammary glandin vitro. Proc Natl Acad Sci USA 76: 5886–5890, 1979

    PubMed  Google Scholar 

  24. Welsch CW, DeHoog JV, O'Connor DH, Sheffield LG: Influence of dietary fat levels on development and hormone responsiveness of mouse mammary gland. Cancer Res 45: 6147–6154, 1985

    PubMed  Google Scholar 

  25. Telang NT: Fatty acid-induced modifications of mouse mammary epithelium as studied in an organ and cell culture system. In: Ip C, Birt DF, Rogers AE, Mettlin C (eds) Dietary Fat and Cancer. Alan R Liss Inc., New York, 1986, pp 707–728

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Telang, N.T., Bradlow, H.L., Kurihara, H. et al. In vitro biotransformation of estradiol by explant cultures of murine mammary tissues. Breast Cancer Res Tr 13, 173–181 (1989). https://doi.org/10.1007/BF01806529

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806529

Key words

Navigation